";s:4:"text";s:3747:" Clin Exp Dermatol 20 (1995): 247-819. Select one or more newsletters to continue. She had initiated therapy 14 days before onset of the generalized rash, for a nonspecific squamous plaque of the trunk. Lowe G, Green C, Jennings P "Hepatitis associated with terbinafine treatment." 2. Hull PR, Vismer HF "Treatment of cutaneous sporotrichosis with terbinafine." Intense Abdominal Pain 6. J Am Acad Dermatol 39 (1998): 115-718. Gupta AK, Kopstein JB, Shear NH "Hypersensitivity reaction to terbinafine."
"Itracanazole, terbinafine possibly linked to liver failure." Isolated cases of prolonged hypogeusia have been reported.Taste disturbance (including taste loss), paresthesia, hypoesthesia, Vomiting, upper abdominal pain, and toothache have been reported with the oral granules.
Liver function studies began to normalize 6 weeks after this drug was discontinued.Pyrexia has been reported with the oral granules; it has also been reported during postmarketing experience with the tablets.Malaise and fatigue have also been reported during postmarketing experience.Changes in the ocular lens and retina have been reported; however, the clinical significance is unknown.Dyschromatopsia, whereby the patient reported a greenish hue in her vision, and photopsia have occurred in a patient after 3 weeks of therapy. Abecassis S, Roujeau JC, Bocquet H, et al. Kovacs MJ, Alshammari S, Guenther L, Bourcier M "Neutropenia and pancytopenia associated with oral terbinafine." https://www.webmd.com/drugs/2/drug-6188/terbinafine-hcl-oral Rzany B, Mockenhaupt M, Gehring W, Schopf E "Stevens-Johnson syndrome after terbinafine therapy." Abnormal Liver Function Tests If experienced, these tend to have a Less Severe expression 1. Rossetti G, Livio F, Roulet E, Hofer MF "Anaphylactic reaction and unrelated, subsequent, known side effects during therapy with thiethylperazine." Int J Dermatol 37 (1998): 410-54. del Palacio Hernandez A, Lopez Gomez S, Gonzalez Lastra F, Moreno Palancar P, Iglesias Diez L "A comparative double-blind study of terbinafine (Lamisil) and griseofulvin in tinea corporis and tinea cruris." Lancet 340 (1992): 72810.